BAYER INTELLECTUAL PROPERTY GMBH et al v. AUSON PHARMACEUTICALS INC. et al > Summary
Court Case Number 2:23-cv-03020
Filing Date Jun 1, 2023
Termination Date Oct 5, 2023
Court New Jersey District Court
Status Transfer/Remand - Transfer to An
JudgesEvelyn Padin
Plaintiff
5Defendant
Plaintiff Attorneys
9BAYER AKTIENGESELLSCHAFT ("BAYER AG")
Attorney Name: Bruce R. Genderson
Williams & Connolly
BAYER AKTIENGESELLSCHAFT ("BAYER AG")
Attorney Name: Dov P. Grossman
Williams & Connolly
BAYER AKTIENGESELLSCHAFT ("BAYER AG")
Attorney Name: Alexander S. Zolan
Williams & Connolly
BAYER AKTIENGESELLSCHAFT ("BAYER AG")
Attorney Name: Kathryn S. Kayali
Williams & Connolly
BAYER AKTIENGESELLSCHAFT ("BAYER AG")
Attorney Name: Julie L. Tavares
Williams & Connolly
JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Thomas D. Rein
Sidley Austin
JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Andrew T. Langford
Sidley Austin
JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Keith J. Miller
Robinson Miller
Defendant Attorneys
3Auson Pharmaceuticals, Inc.
Attorney Name: Paul W. Kalish
Fox Rothschild
Auson Pharmaceuticals, Inc.
Attorney Name: Gerard Patrick Norton
Fox Rothschild
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 10828310 | Reducing the risk of cardiovascular events | Nov 10, 2020 |
| 09539218 | Prevention and treatment of thromboembolic disorders | Jan 10, 2017 |
